Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon

被引:270
作者
Talele, Tanaji T. [1 ]
机构
[1] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA
关键词
ALDOSE REDUCTASE HOLOENZYME; SMALL MOLECULES; HEPATITIS-C; DRUG DISCOVERY; ENANTIOSELECTIVE SYNTHESIS; RESOLUTION STRUCTURES; NATURAL-PRODUCTS; PARP INHIBITOR; HIGHLY POTENT; ERK INHIBITOR;
D O I
10.1021/acs.jmedchem.0c00829
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quaternary carbon bears four other carbon substituents or combination of four non-hydrogen substituents at four vertices of a tetrahedron. The spirocyclic quaternary carbon positioned at the center of a bioactive molecule offers conformational rigidity, which in turn reduces the penalty for conformational entropy. The quaternary carbon is a predominant feature of natural product structures and has been associated with more effective and selective binding to target proteins compared to planar compounds with a high sp(2) count. The presence of a quaternary carbon stereocenter allows the exploration of novel chemical space to obtain new molecules with enhanced three-dimensionality. These characteristics, coupled to an increasing awareness to develop sp(3)-rich molecules, boosted utility of quaternary carbon stereocenters in bioactive compounds. It is hoped that this Perspective will inspire the chemist to utilize quaternary carbon stereocenters to enhance potency, selectivity, and other drug-like properties.
引用
收藏
页码:13291 / 13315
页数:25
相关论文
共 162 条
[1]   Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma [J].
af Rosenschold, Magnus Munck ;
Johannesson, Petra ;
Nikitidis, Antonios ;
Tyrchan, Christian ;
Chang, Hui-Fang ;
Ronn, Robert ;
Chapman, Dave ;
Ullah, Victoria ;
Nikitidis, Grigorios ;
Glader, Pernilla ;
Kack, Helena ;
Bonn, Britta ;
Wagberg, Fredrik ;
Bjorkstrand, Eva ;
Andersson, Ulf ;
Swedin, Linda ;
Rohman, Mattias ;
Andreasson, Theresa ;
Bergstrom, Eva Lamm ;
Jiang, Fanyi ;
Zhou, Xiao-Hong ;
Lundqvist, Anders J. ;
Malmberg, Anna ;
Ek, Margareta ;
Gordon, Euan ;
Pettersen, Anna ;
Ripa, Lena ;
Davis, Andrew M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) :7769-7787
[2]   Two-and Three-dimensional Rings in Drugs [J].
Aldeghi, Matteo ;
Malhotra, Shipra ;
Selwood, David L. ;
Chan, Ah Wing Edith .
CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (04) :450-461
[3]   The State of the Art of Chemical Biology [J].
Altmann, Karl-Heinz ;
Buchner, Johannes ;
Kessler, Horst ;
Diederich, Francois ;
Kraeutler, Bernhard ;
Lippard, Stephen ;
Liskamp, Rob ;
Mueller, Klaus ;
Nolan, Elizabeth M. ;
Samori, Bruno ;
Schneider, Gisbert ;
Schreiber, Stuart L. ;
Schwalbe, Harald ;
Toniolo, Claudio ;
van Boeckel, Constant A. A. ;
Waldmann, Herbert ;
Walsh, Christopher T. .
CHEMBIOCHEM, 2009, 10 (01) :16-29
[4]   Structural basis for RNA replication by the hepatitis C virus polymerase [J].
Appleby, Todd C. ;
Perry, Jason K. ;
Murakami, Eisuke ;
Barauskas, Ona ;
Feng, Joy ;
Cho, Aesop ;
Fox, David, III ;
Wetmore, Diana R. ;
McGrath, Mary E. ;
Ray, Adrian S. ;
Sofia, Michael J. ;
Swaminathan, S. ;
Edwards, Thomas E. .
SCIENCE, 2015, 347 (6223) :771-775
[5]   Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies [J].
Appleman, Leonard J. ;
Beumer, Jan H. ;
Jiang, Yixing ;
Lin, Yan ;
Ding, Fei ;
Puhalla, Shannon ;
Swartz, Leigh ;
Owonikoko, Taofeek K. ;
Harvey, R. Donald ;
Stoller, Ronald ;
Petro, Daniel P. ;
Tawbi, Hussein A. ;
Argiris, Athanassios ;
Strychor, Sandra ;
Pouquet, Marie ;
Kiesel, Brian ;
Chen, Alice P. ;
Gandara, David ;
Belani, Chandra P. ;
Chu, Edward ;
Ramalingam, Suresh S. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) :1289-1301
[6]   Inhibition of cancer growth by resveratrol is related to its low bioavailability [J].
Asensi, M ;
Medina, I ;
Ortega, A ;
Carretero, J ;
Baño, MC ;
Obrador, E ;
Estrela, JM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) :387-398
[7]   Improving Nonspecific Binding and Solubility: Bicycloalkyl Groups and Cubanes as para-Phenyl Bioisosteres [J].
Auberson, Yves P. ;
Brocklehurst, Cara ;
Furegati, Markus ;
Fessard, Thomas C. ;
Koch, Guido ;
Decker, Andrea ;
La Vecchia, Luigi ;
Briard, Emmanuelle .
CHEMMEDCHEM, 2017, 12 (08) :590-598
[8]   The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain [J].
Beisner, Daniel R. ;
Langerak, Petra ;
Parker, Albert E. ;
Dahlberg, Carol ;
Otero, Francella J. ;
Sutton, Sue E. ;
Poirot, Laurent ;
Barnes, Whitney ;
Young, Michael A. ;
Niessen, Sherry ;
Wiltshire, Tim ;
Bodendorf, Ursula ;
Martoglio, Bruno ;
Cravatt, Benjamin ;
Cooke, Michael P. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (01) :23-30
[9]   Adaptive immunity in HBV infection [J].
Bertoletti, Antonio ;
Ferrari, Carlo .
JOURNAL OF HEPATOLOGY, 2016, 64 :S71-S83
[10]   MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology [J].
Boga, Sobhana Babu ;
Deng, Yongqi ;
Zhu, Liang ;
Nan, Yang ;
Cooper, Alan B. ;
Shipps, Gerald W., Jr. ;
Doll, Ronald ;
Shih, Neng-Yang ;
Zhu, Hugh ;
Sun, Robert ;
Wang, Tong ;
Paliwal, Sunil ;
Tsui, Hon-Chung ;
Gao, Xiaolei ;
Yao, Xin ;
Desai, Jagdish ;
Wang, James ;
Alhassan, Abdul Basit ;
Kelly, Joseph ;
Patel, Mehul ;
Muppalla, Kiran ;
Gudipati, Subrahmanyam ;
Zhang, Li-Kang ;
Buevich, Alexei ;
Hesk, David ;
Carr, Donna ;
Dayananth, Priya ;
Black, Stuart ;
Mei, Hong ;
Cox, Kathleen ;
Sherborne, Bradley ;
Hruza, Alan W. ;
Xiao, Li ;
Jin, Weihong ;
Long, Brian ;
Liu, Gongjie ;
Taylor, Stacey A. ;
Kirschmeier, Paul ;
Windsor, William T. ;
Bishop, Robert ;
Samatar, Ahmed A. .
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07) :761-767